Ulinastatin in the conservative therapy of chronic pancreatitis

Mirvosit M. Karimov, Pulat S. Zufarov, Go’zal N. Sobirova, Pulatova I. Nargiza, Shahlo S. Aripdjanova

dc.contributor.author	Mirvosit M. Karimov, Pulat S. Zufarov, Go’zal N. Sobirova, Pulatova I. Nargiza, Shahlo S. Aripdjanova
dc.date.accessioned	2022-10-07T05:32:30Z
dc.date.available	2022-10-07T05:32:30Z
dc.date.issued	2022
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/2509
dc.description.abstract	The article presents the results of the anti-inflammatory efficacy of the new generation protease inhibitor ulinastatin in the treatment of exacerbation of chronic pancreatitis of moderate severity. It is shown that exacerbation of chronic pancreatitis of alimentary, alcoholic and biliary etiology was expressed by abdominal pain and dyspeptic symptoms. An increase in the level of serum aminotransferases, bilirubin and alpha amylase was noted, which was accompanied by a significant increase in the activity of pro-inflammatory cytokines. The use of ulinastatin in the complex of pharmacotherapy of chronic pancreatitis contributed to the effective relief of exacerbation of pancreatitis, which was due to the anticytokine effect of the drug	en_US
dc.language.iso	en	en_US
dc.publisher	Tаshkent	en_US
dc.subject	Chronic pancreatitis, etiology, treatment, clinical, adverse reaction.	en_US
dc.title	Ulinastatin in the conservative therapy of chronic pancreatitis	en_US
dc.type	Article	en_US